Abstract: The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.

Abstract: A process for making a biodegradable composition involving: (a) providing from about 20 to 80% by weight of C8-22 fatty alcohol; (b) providing from about 20 to 80% by weight of a ring opening product of a C8-18 1,2-epoxyalkane with ethylene glycol; (c) combining (a) and (b) to form a reaction mixture; and (d) reacting the reaction mixture with ethylene oxide, with the proviso that the ethylene oxide is used in an amount of from about 5 to 100 mol ethylene oxide per mol of free OH groups present in the reaction mixture.

Abstract: A process for making a biodegradable composition involving: (a) providing from about 20 to 80% by weight of C8-22 fatty alcohol; (b) providing from about 20 to 80% by weight of a ring opening product of a C8-18 1,2-epoxyalkane with ethylene glycol; (c) combining (a) and (b) to form a reaction mixture; and (d) reacting the reaction mixture with ethylene oxide, with the proviso that the ethylene oxide is used in an amount of from about 5 to 100 mol ethylene oxide per mol of free OH groups present in the reaction mixture.

Abstract: Water-soluble nonionic polyurethanes as protective colloids for the polymerization of olefinically unsaturated monomers in aqueous medium wherein the water-soluble nonionic polyurethanes have been prepared by reacting a) organic polyisocyanates with b) water-soluble polyalkylene glycols containing at least 70% by weight of ethylene glycol groups and with c) polyhydric branched alcohols containing at least three hydroxyl groups per molecule and wherein the equivalent ratio of b) to c) is in the range from 1:0.01 to 1:10 and the equivalent ratio of [b)+c)] to a) is in the range from 1:0.6 to 1:0.85.